Biomedical Sciences

Biomedical Sciences Experts

Nigel J Rulewski

Quintiles Inc., USA
United States of America


Nigel J Rulewski has 25+ years’ experience in Drug Development and Regulatory Affairs, in both large and small pharma, Venture Capital and Pharmaceutical Business Development. He is presently VP, Strategic Drug Development Group and Head, Biosimilar Center of Excellence, at Quintiles. He has planned the development of biosimilar versions of EPO, GCSF, peg-GCSF, remicade, humira, enbrel, rituximab, avastin and herceptin. He earned his Medical degree at St. Bartholomew’s Medical School, University of London and also holds a Diploma in Child Health, Royal College of Physicians and a Diploma of Royal College of Obstetricians and Gynecologists

Research Interest

Biosimilars, Biologics, Biomedicines

Global Experts from United States of America

Global Experts in Subject

Share This Profile